Literature DB >> 27107995

In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma.

Marina Bianchi1, Antonio Clavenna2, Daniele Piovani2, Maurizio Bonati2.   

Abstract

Entities:  

Keywords:  Anti-asthmatic drugs; Asthma; Pediatrics

Mesh：

Substances：

Year:  2016        PMID： 27107995     DOI： 10.1007/s10654-016-0146-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  5 in total

1.  Italian paediatricians and off-label prescriptions: loyal to regulatory or guideline standards?

Authors:  Chiara Pandolfini; Rita Campi; Antonio Clavenna; Teresa Cazzato; Maurizio Bonati
Journal:  Acta Paediatr       Date:  2005-06       Impact factor: 2.299

2.  Asthma diagnosis vs. analysis of anti-asthmatic prescriptions to identify asthma in children.

Authors:  Marina Bianchi; Antonio Clavenna; Marco Sequi; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2011-03-25       Impact factor: 2.953

3.  Antibiotic exposure in the first year of life and later treated asthma, a population based birth cohort study of 143,000 children.

Authors:  Gisella Pitter; Jonas Filip Ludvigsson; Pierantonio Romor; Loris Zanier; Renzo Zanotti; Lorenzo Simonato; Cristina Canova
Journal:  Eur J Epidemiol       Date:  2015-05-09       Impact factor: 8.082

4.  Assessment of pediatric asthma drug use in three European countries; a TEDDY study.

Authors:  Elif Fatma Sen; Katia M C Verhamme; Antje Neubert; Yingfen Hsia; Macey Murray; Mariagrazia Felisi; Carlo Giaquinto; Geert W 't Jong; Gino Picelli; Eugenio Baraldi; Alfredo Nicolosi; Adriana Ceci; Ian C Wong; Miriam C J M Sturkenboom
Journal:  Eur J Pediatr       Date:  2010-09-02       Impact factor: 3.183

5.  Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new users.

Authors:  Marina Bianchi; Antonio Clavenna; Marco Sequi; Angela Bortolotti; Ida Fortino; Luca Merlino; Maurizio Bonati
Journal:  BMC Pulm Med       Date:  2011-10-17       Impact factor: 3.317
  5 in total
  2 in total

1.  Reply to Bianchi et al.: In Italy anti-asthmatic drug prescription is not always a reliable proxy of asthma.

Authors:  Gisella Pitter; Cristina Canova
Journal:  Eur J Epidemiol       Date:  2016-04-21       Impact factor: 8.082

2.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.